A plasma metabolome‐derived model predicts severe liver outcomes of nonalcoholic fatty liver disease in the UK Biobank
Diabetes, Obesity and Metabolism · 2025
DOI: 10.1111/dom.16533 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes, Obesity and Metabolism, 2025. Verfasst von Xiaoqin Xu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Metabolism, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease, Metabolome, Liver Cirrhosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Science and Technology Commission of Shanghai Municipality, Major Science and Technology Innovation Program of the Shanghai Municipal Education Commission.
Abstract (Originalsprache)
Aims
Severe liver disease (SLD) in nonalcoholic fatty liver disease (NAFLD) is often diagnosed late due to the long asymptomatic period of progressive fibrosis. We aimed to identify metabolomic profiles associated with SLD and develop a predictive model to improve risk stratification. Materials and Methods We enrolled 59 579 UK Biobank participants with a positive fatty liver index (≥60) and plasma metabolomic profiles, evaluating the incidence of cirrhosis, decompensated liver disease, hepatocellular carcinoma and/or liver transplantation. Cox regression models were applied to evaluate the associations between individual metabolites and SLD risk. Using an interpretable machine‐learning framework, a metabolomics‐integrated nomogram prediction model was developed and compared with conventional scoring systems.
Results
After Bonferroni correction, 110 of 249 metabolites were significantly associated with the risk of incident SLD in the Cox regression model. Among them, 11 metabolites were ultimately prioritised as predictors to construct the metabolomic score based on the optimal machine learning algorithm. The nomogram integrating metabolomic score, gamma glutamyltransferase, platelet count, waist/hip ratio, diabetes and sex showed better predictive capacity of 10‐year SLD risk (area under the receiver operating characteristic 0.841 [95% CI: 0.800–0.881]) than the fibrosis‐4 index (0.712, 0.662–0.763), NAFLD fibrosis score (0.659, 0.609–0.709) and aspartate aminotransferase‐to‐platelet ratio index (0.705, 0.652–0.759) in the validation cohort. Categorisation of participants according to selected cutoffs revealed a distinct cumulative risk of SLD, with a hazard ratio of 25.71 (95% CI: 17.10–38.66) for the high‐risk group compared with the low‐risk group.
Conclusions
Integrating plasma metabolomics with routine indicators enhanced the predictive capacity for severe liver outcomes of NAFLD, which shows the potential benefits in disease risk stratification and precise interventions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Endocrinology and Metabolism, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Department of Big Data in Health Science, School of Public Health, Zhejiang University School of Medicine, Hangzhou, China.
- Department of Medical Sciences, Uppsala University, Uppsala, Sweden.
- Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
ORCID-Profile: Ningjian Wang, Bin Wang, Yingli Lu
Förderung
- National Natural Science Foundation of China
- Science and Technology Commission of Shanghai Municipality
- Major Science and Technology Innovation Program of the Shanghai Municipal Education Commission
- Biobank Project
Zitieren
APA
Xu, X., Li, J., Fu, Y., Li, J., Shen, W., Tan, X., Wang, N., Wang, B., & Lu, Y. (2025). A plasma metabolome‐derived model predicts severe liver outcomes of nonalcoholic fatty liver disease in the UK Biobank. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.16533
Vancouver
Xu X, Li J, Fu Y, Li J, Shen W, Tan X, et al. A plasma metabolome‐derived model predicts severe liver outcomes of nonalcoholic fatty liver disease in the UK Biobank. Diabetes, Obesity and Metabolism. 2025. doi:10.1111/dom.16533
BibTeX
@article{Xu2025,
author = {Xu, Xiaoqin and Li, Jiang and Fu, Yanqi and Li, Jie and Shen, Wenqi and Tan, Xiao and Wang, Ningjian and Wang, Bin and Lu, Yingli},
title = {A plasma metabolome‐derived model predicts severe liver outcomes of nonalcoholic fatty liver disease in the UK Biobank},
journal = {Diabetes, Obesity and Metabolism},
year = {2025},
doi = {10.1111/dom.16533}
}
EUVIMED